1-3 of 3
Marshall E. Hicks
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

George R. Blumenschein, Jr, Pierre Saintigny, Suyu Liu, Edward S. Kim, Anne S. Tsao, Roy S. Herbst, Christine Alden, J. Jack Lee, Ximing Tang, David J. Stewart, Merrill S. Kies, Frank V. Fossella, Hai T. Tran, L. Mao, Marshall E. Hicks, Jeremy Erasmus, Jr, Sanjay Gupta, Luc Girard, Michael Peyton, Lixia Diao, Jing Wang, Suzanne E. Davis, John D. Minna, Ignacio Wistuba, Waun K. Hong, John V. Heymach, Scott M. Lippman
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (24): 6967–6975.
https://doi.org/10.1158/1078-0432.CCR-12-1818
Published: 16 December 2013
View article titled, Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial
Open the PDF for Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial in another window
Includes: Supplementary data
Journal Articles

Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas

Ralph S. Freedman, Saroj Vadhan-Raj, Cherie Butts, Cherylyn Savary, Bohuslav Melichar, Claire Verschraegen, John J. Kavanagh, Marshall E. Hicks, Lawrence B. Levy, Jody K. Folloder, Michael E. Garcia
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5228–5237.
Published: 12 November 2003
View article titled, Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas
Open the PDF for Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas in another window
Journal Articles

Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma

Renato Lenzi, Michael Rosenblum, Claire Verschraegen, Andrzej P. Kudelka, John J. Kavanagh, Marshall E. Hicks, Eric A. Lang, Michael A. Nash, Lawrence B. Levy, Michael E. Garcia, Chris D. Platsoucas, James L. Abbruzzese, Ralph S. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3686–3695.
Published: 01 December 2002
View article titled, Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma
Open the PDF for Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma in another window